Clinical Trial

Virtual Reality Exposure for Vaginismus: A Replicated Single-Case Design

Study acronym: VIVID 2
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Vaginismus is a sexual dysfunction characterized by involuntary tightening of the pelvic floor muscles, preventing vaginal intercourse. It is defined by an intense fear of vaginal penetration, leading to persistent difficulties with vaginal intercourse and gynaecological exams. Psychological factors play a significant role in vaginismus. If the pelvic floor muscle tightening represents a defensive reflex, then treatment using a gradual exposure to feared stimuli using virtual reality may lead to an extinction of the phobic response, and to amelioration of vaginismus. If effective, the use of virtual reality technology can directly improve clinical care offered to those suffering from vaginismus.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-03; most recent amendment 2026-06-26.
Status change: Recruiting → Active, Not Recruiting 2026-06-26
Status change: Not Yet Recruiting → Recruiting 2025-09-20
Trial Details
NCT Number NCT06923306
Lead Sponsor University of British Columbia
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions Vaginismus
Enrollment 20 participants
Start Date 2025-04-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-30